Acticor Biotech SAS (ALACT.PA) - Stock Prices, Stock Peers & Analysis

Home
ALACT.PA

Company Name	Acticor Biotech SAS
Symbol	ALACT.PA
Currency	EUR
Price	0.53
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	8,350,270
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.22 - 5.32
Industry	Biotechnology
Sector	Healthcare
CEO	Dr. Gilles Avenard M.D.
Website	https://acticor-biotech.com

An error occurred while fetching data.

About Acticor Biotech SAS

Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for